Search

everythinglearnresearchcommunity

for

Search:↓

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

A specific RNA helps increase the growth of skin cells in Liaoning cashmere goats by working with a protein to boost a growth-related gene.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

RNase L hinders hair follicle regeneration by altering immune signals.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

LRIG1 is linked to better survival in Merkel cell carcinoma.

The LTF gene may help predict and manage nonspecific orbital inflammation.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Lrig1 marks a unique group of stem cells in mouse skin that can become different skin cell types.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

RNase L hinders hair growth by altering immune signals.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

The IRF2BP2 gene affects sheep fleece quality by influencing fiber traits.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

iL-PRF treatment improves hair growth for androgenetic alopecia.

Certain immune cells worsen post-surgery gut paralysis by activating a specific immune response.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Lrig1 marks a unique group of stem cells in mouse skin that can become different skin cell types.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.